共 24 条
- [1] CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells..T Kuwabara;F Ishikawa;T Yasuda;K Aritomi;H Nakano;Y Tanaka;Y Okada;M Lipp;T Kakiuchi;.J Immunol.2009,
- [3] Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec; Canada: a multicentre retrospective cohort study..[J].Musonera Jean B;Valiquette Louis;Baron Geneviève;Milord François;Marcoux Dominique;Thivierge Karine;BedardDallaire Samuel;Pelletier Andrée A;Lachance Raphaël;Bourget Jeremy;Simard Catherine;Cantin Emmanuelle;Abbasi Farhad;Haraoui LouisPatrick;Carignan Alex.CMAJ open.2022, 2
- [4] Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study..[J].Aucott John N;Yang Ting;Yoon Isaac;Powell Debra;Geller Steven A;Rebman Alison W.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.2022,
- [5] A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease [J]. PLOS ONE, 2022, 17 (10):
- [6] Characterizing Post-treatment Lyme Disease Syndrome: A Mixed Methods Study of Patients at a Lyme Disease Clinic in Rhode Island..[J].Vargas Sara E;Guillen Melissa;Stout Claire D;McCarthy Meghan;Canfield Dylan;Tolliver Eric;Cunnane Sabrina;Flanigan Timothy.Rhode Island medical journal (2013).2021, 8
- [8] Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology [J]. MEDICINA-LITHUANIA, 2021, 57 (05):
- [9] PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews..[J].Page Matthew J;Moher David;Bossuyt Patrick M;Boutron Isabelle;Hoffmann Tammy C;Mulrow Cynthia D;Shamseer Larissa;Tetzlaff Jennifer M;Akl Elie A;Brennan Sue E;Chou Roger;Glanville Julie;Grimshaw Jeremy M;Hróbjartsson Asbjørn;Lalu Manoj M;Li Tianjing;Loder Elizabeth W;MayoWilson Evan;McDonald Steve;McGuinness Luke A;Stewart Lesley A;Thomas James;Tricco Andrea C;Welch Vivian A;Whiting Penny
- [10] Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study [J]. BMJ OPEN, 2021, 11 (01):